# Postoperative Effects of TAP Block Versus QLB Type 2 Block

> **NCT03126084** · PHASE4 · COMPLETED · sponsor: **Bozyaka Training and Research Hospital** · enrollment: 90 (actual)

## Conditions studied

- Inguinal Hernia
- Postoperative Pain

## Interventions

- **DRUG:** Acetaminophen
- **DRUG:** 0.25% Bupivacaine
- **DRUG:** 0.5% Bupivacaine+Glucose
- **DRUG:** Tramadol HCl
- **PROCEDURE:** Inguinal Hernia Repair
- **DRUG:** 0.25% Bupivacaine

## Key facts

- **NCT ID:** NCT03126084
- **Lead sponsor:** Bozyaka Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-02
- **Primary completion:** 2017-11-11
- **Final completion:** 2017-11-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03126084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03126084, "Postoperative Effects of TAP Block Versus QLB Type 2 Block". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03126084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*